Electrophysiology catheter design
The present invention relates to a method, device, and system for improved mapping and/or ablation of a tissue. The device may generally include an elongate body and a distal assembly affixed to the elongate body that includes a treatment electrode having a conductive mapping region and a selectively conductive ablation region that is conductive of high-frequency current and substantially non-conductive of low-frequency current. Alternatively, the device may generally include a treatment electrode having a conductive mapping or ablation region and a region that is coated with an electrically insulated but thermally conductive layer.
1. A method of mapping and ablating tissue comprising:
providing a device including a distal assembly comprising one or more conductive regions and one or more selectively conductive regions, the one or more conductive regions and one or more selectively conductive regions being in electrical communication with a high-frequency energy source, and the one or more selectively conductive regions being conductive of high-frequency energy and substantially non-conductive of low-frequency electric current;
positioning the distal assembly in contact with an area of target tissue;
recording at least one electrogram from the area of target tissue with the conductive region of the distal assembly;
determining whether the at least one electrogram indicates a presence of an aberrant electrical pathway within the area of target tissue; and
when the presence of an aberrant electrical pathway within the area of target tissue is indicated, transmitting a high-frequency energy to the conductive region and the selectively conductive region, the conductive region and selectively conductive region ablating at least a portion of the area of target tissue.
2. The method of claim 1 , wherein the distal assembly further comprises a housing, and wherein each of the one or more conductive regions includes a monophasic action potential recording electrode affixed to the housing, the selectively conductive region being the housing.
3. The method of claim 1 , wherein the high-frequency energy is radiofrequency energy.
4. The method of claim 1 , wherein the one or more selectively conductive regions includes an outer layer.
5. The method of claim 4 , wherein the outer layer is an oxidized layer.
6. The method of claim 5 , wherein the outer layer includes at least one selected from a group consisting of: tungsten, titanium, tantalum, hafnium, niobium, zirconium, and mixtures thereof.
7. The method of claim 4 , wherein the outer layer includes at least one selected from a group consisting of: oxidized aluminum, oxidized tungsten, oxidized titanium, oxidized tantalum, oxidized hafnium, oxidized niobium, oxidized zirconium, and mixtures thereof.
8. The method of claim 4 , wherein the outer layer includes at least one selected from a group consisting of: oxidized tungsten, oxidized titanium, oxidized tantalum, oxidized hafnium, oxidized niobium, oxidized zirconium, and mixtures thereof.
9. The method of claim 1 , wherein the one or more conductive regions and the one or more selectively conductive regions are made of a metal, and wherein the one or more selectively conductive regions include an oxide of the metal.
10. The method of claim 9 , wherein the oxide is conductive of high-frequency energy and substantially non-conductive of low-frequency current.
11. A method of mapping and ablating tissue comprising:
providing a device including a distal assembly having one or more conductive regions and one or more selectively conductive regions, the one or more conductive regions and one or more selectively conductive regions being in electrical communication with a high-frequency energy source, and the one or more selectively conductive regions being conductive of high-frequency energy and substantially non-conductive of low-frequency electric current;
positioning the distal assembly in contact with an area of target tissue;
recording at least one electrogram from the area of target tissue with the conductive region of the distal assembly;
determining whether the at least one electrogram indicates a presence of an aberrant electrical pathway within the area of target tissue; and
when the presence of an aberrant electrical pathway within the area of target tissue is indicated, transmitting a high-frequency energy to the conductive region and the selectively conductive region, the conductive region and selectively conductive region ablating at least a portion of the area of target tissue,
wherein the one or more selectively conductive regions includes an outer layer.
12. The method of claim 11 , wherein the outer layer is an oxidized layer.
13. The method of claim 12 , wherein the outer layer includes at least one selected from a group consisting of: aluminum, tungsten, titanium, tantalum, hafnium, niobium, zirconium, and mixtures thereof.